Drug profile · INN
pemetrexed dipotassium
AXTLE
- US status
- approved
- Patents linked
- 0
- News articles
- 0
Quick answer
pemetrexed dipotassium (AXTLE) is an FDA-listed pharmaceutical active ingredient. Route of administration: intravenous. Current US regulatory status: approved.
Key facts
INN pemetrexed dipotassium
Brand AXTLE
Route INTRAVENOUS
Formulation POWDER
Frequently asked questions
What is pemetrexed dipotassium?
pemetrexed dipotassium (AXTLE) is an FDA-listed pharmaceutical active ingredient. Route of administration: intravenous. Current US regulatory status: approved.
What is the brand name for pemetrexed dipotassium?
AXTLE is a marketed brand name for pemetrexed dipotassium. Check FDA Drugs@FDA for the current US label holder and prescribing information.
What is the US approval status of pemetrexed dipotassium?
pemetrexed dipotassium has approved status in the United States according to our Drugs@FDA-derived records. Verify on the official FDA label before clinical or commercial decisions.